Hysan Schnupfenspray (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. When sprayed into the nose, it binds to α‑receptors on the smooth muscle of nasal blood vessels, causing vasoconstriction. This reduces vascular leakage and edema, quickly opening the nasal passages.

The appropriate dose is determined by the prescribing healthcare professional. Typically, the label advises no more than two sprays per nostril every 12 hours and not to exceed three days of continuous use, but the exact regimen should follow the prescriber’s instructions.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using the spray.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Hysan Schnupfenspray uses Xylometazoline Hydrochloride, an alpha‑adrenergic agonist similar to oxymetazoline. Both provide rapid relief of congestion, but Xylometazoline may have a slightly shorter duration of action, allowing more flexible dosing. Choice often depends on physician preference, patient response, and formulation availability.

Store the spray at room temperature, ideally below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product stability.

The spray is applied directly into each nostril. The user tilts the head slightly forward, inserts the nozzle, and presses down to deliver the recommended number of sprays. The medication should be used as directed by a healthcare professional.

Serious risks include severe hypertension, cardiac arrhythmias, and rebound nasal congestion (rhinitis medicamentosa) if used for more than three consecutive days. Rarely, allergic reactions or nasal tissue damage may occur, requiring immediate medical attention.

Individuals with known hypersensitivity to Xylometazoline Hydrochloride or any component of the formulation should avoid use. Patients with uncontrolled hypertension, severe coronary artery disease, or those using monoamine oxidase inhibitors should consult a physician before using the spray.